Page last updated: 2024-10-26

doxapram and Pyrexia

doxapram has been researched along with Pyrexia in 1 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jansen, JE1
Sorensen, AI1
Naesh, O1
Erichsen, CJ1
Pedersen, A1

Trials

1 trial available for doxapram and Pyrexia

ArticleYear
Effect of doxapram on postoperative pulmonary complications after upper abdominal surgery in high-risk patients.
    Lancet (London, England), 1990, Apr-21, Volume: 335, Issue:8695

    Topics: Abdomen; Adult; Aged; Blood Gas Analysis; Cough; Double-Blind Method; Doxapram; Drug Administration

1990